Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121741405 | 12174140 | 5 | F | 20140723 | 20160917 | 20160314 | 20160920 | EXP | BR-ROCHE-1451719 | ROCHE | 90.74 | YR | F | Y | 58.00000 | KG | 20160920 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121741405 | 12174140 | 1 | PS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | LATEST INFUSION ON 15/AUG/2015. | 103705 | 1 | G | SOLUTION FOR INFUSION | |||||||
| 121741405 | 12174140 | 2 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | LATEST INFUSION ON15/MAR/2014. | 103705 | 1 | G | SOLUTION FOR INFUSION | |||||||
| 121741405 | 12174140 | 3 | C | METHOTREXATE. | METHOTREXATE | 1 | Subcutaneous | 0 | 20 | MG | /wk | ||||||||
| 121741405 | 12174140 | 4 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | 0 | ||||||||||||
| 121741405 | 12174140 | 5 | C | VONAU FLASH | 2 | 0 | |||||||||||||
| 121741405 | 12174140 | 6 | C | BUSCOPAN | BUTYLSCOPOLAMINE BROMIDE | 1 | 0 | ||||||||||||
| 121741405 | 12174140 | 7 | C | KETOROLAC | KETOROLACKETOROLAC TROMETHAMINE | 1 | Sublingual | 0 | |||||||||||
| 121741405 | 12174140 | 8 | C | TYLEX (BRAZIL) | ACETAMINOPHENCODEINE PHOSPHATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121741405 | 12174140 | 1 | Rheumatoid arthritis |
| 121741405 | 12174140 | 3 | Rheumatoid arthritis |
| 121741405 | 12174140 | 4 | Gastric disorder |
| 121741405 | 12174140 | 7 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121741405 | 12174140 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121741405 | 12174140 | Arthralgia | |
| 121741405 | 12174140 | Asthenia | |
| 121741405 | 12174140 | Bronchiolitis | |
| 121741405 | 12174140 | Hyponatraemia | |
| 121741405 | 12174140 | Intervertebral disc disorder | |
| 121741405 | 12174140 | Intervertebral disc protrusion | |
| 121741405 | 12174140 | Malaise | |
| 121741405 | 12174140 | Obstruction | |
| 121741405 | 12174140 | Pancreatitis | |
| 121741405 | 12174140 | Spinal column stenosis | |
| 121741405 | 12174140 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121741405 | 12174140 | 1 | 20120914 | 0 | ||
| 121741405 | 12174140 | 2 | 20130222 | 0 | ||
| 121741405 | 12174140 | 3 | 20130115 | 0 |